Cargando…
A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells
Aptamers have the potential to be used as targeting ligands for cancer treatment as they form unique spatial structures. Methods: In this study, a DNA aptamer (T1) that accumulates in the tumor microenvironment was identified through in vivo selection and validation in breast cancer models. The use...
Autores principales: | Liu, Haoran, Mai, Junhua, Shen, Jianliang, Wolfram, Joy, Li, Zhaoqi, Zhang, Guodong, Xu, Rong, Li, Yan, Mu, Chaofeng, Zu, Youli, Li, Xin, Lokesh, Ganesh L., Thiviyanathan, Varatharasa, Volk, David E., Gorenstein, David G., Ferrari, Mauro, Hu, Zhongbo, Shen, Haifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743458/ https://www.ncbi.nlm.nih.gov/pubmed/29290791 http://dx.doi.org/10.7150/thno.21342 |
Ejemplares similares
-
Tracking Biodistribution of Myeloid-Derived Cells in Murine Models of Breast Cancer
por: Li, Jun, et al.
Publicado: (2019) -
Cancer stem cells are enriched in Fanconi anemia head and neck squamous cell carcinomas
por: WU, JEAN, et al.
Publicado: (2014) -
Identification of an Aptamer With Binding Specificity to Tumor-Homing Myeloid-Derived Suppressor Cells
por: Tian, Shaohui, et al.
Publicado: (2022) -
Aptamer technology: a new approach to treat lymphoma?
por: Zu, Youli
Publicado: (2020) -
A Highlight of Recent Advances in Aptamer Technology and Its Application
por: Sun, Hongguang, et al.
Publicado: (2015)